Investigators have recently demonstrated that replenishing the gut microbiome with Akkermansia muciniphila in germ-free mice receiving FMTs from patients responding to immunotherapy promotes CCR9 + CXCR3 + CD4 + T-lymphocyte migration into tumor beds [16]. Here, CD4 is linked to neoplasm.